Ecuador vs Mongolia: Treatment success rate for patients treated for MDR-TB
Ecuador
65.0%
in 2022
Mongolia
65.0%
in 2022
Ecuador rank
113th
Mongolia rank
113th
Treatment success rate for patients treated for MDR-TB over time
- Ecuador
- Mongolia
How they compare
Ecuador currently reports 65.0% against 65.0% in Mongolia, a difference of 0.0%.
Across all 14 years both countries report, Mongolia has been ahead every year.
Ecuador ranks 113th and Mongolia ranks 113th of 163 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 57.8% | 73.8% | 16.0% | Mongolia |
| 2010s | 48.7% | 63.7% | 15.0% | Mongolia |
| 2020s | 53.0% | 72.0% | 19.0% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Ecuador or Mongolia?
- Ecuador, at 65.0% against 65.0% in Mongolia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Ecuador and Mongolia?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Mongolia?
- 14 years are reported by both, from 2006 to 2022.
- How do Ecuador and Mongolia rank globally for treatment success rate for patients treated for mdr-tb?
- Ecuador ranks 113th and Mongolia ranks 113th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.